|
Status
|
Topic selection
|
|
Technology type
|
Medicine
|
|
Decision
|
Not selected
|
|
Reason for decision
|
Not eligible for Health Technology Evaluation guidance
|
|
Further information
|
Decision makers have concluded that this technology will not progress as a potential technology appraisal or a highly specialised technology. As is consistent with decisions made relating to other semaglutide products for treating type 2 diabetes, your product will now be routed to the NICE Centre for Guidelines where the topic will be considered as part of the ongoing update to NG28 Project information | Type 2 diabetes in adults: management (medicines update) | Guidance | NICE.
|
| ID number |
11791
|
Project Team
| Project lead |
Danielle Lees |
Email enquiries
For further information on how we select topics for development, please see our page about topic selection